What Does MDMA Stand For On A MDMA Ecstasy/Molly Test?
The total quantity of MDMA consumed in Europe is reached by multiplying the number of users by the amount used, combining prevalence data from general population surveys and the amount used from the EWSD. The basic approach used to estimate the value of the European MDMA market is to gauge the quantity of MDMA consumed in Europe and multiply it by its price (EMCDDA, 2019a). Wastewater data also reflect the predominant use of ecstasy in recreational settings, with more than three quarters of cities reporting that higher loads of MDMA were present in wastewater during the weekend than during weekdays in 2022. This data explorer enables you to view our data on the prevalence of MDMA use by recall period and age range. Of the 69 cities that have data for 2022 and 2023, 42 reported an increase, 11 reported a stable situation and 16 a decrease. Wastewater data from 2023 complement the available data from general population surveys, drug treatment and hospital emergency admissions; however, wastewater is not uniformly analysed across the European Unio
However, these data are not generalisable either, and as such should be interpreted with caution. These products typically contain MDMA hydrochloride (see Box Forms of MDMA present on the European market).
Where prevalence is higher, it may suggest that MDMA is no longer a niche or subcultural drug limited to dance clubs and parties in those markets. Some of the high-strength ecstasy tablets are scored to allow consumers to divide them into smaller portions. These buy ecstasy identifications of high-strength ecstasy tablets prompted harm reduction organisations to issue alerts. In December 2023, beige-golden ecstasy pills with an Audi-logo containing over 300 milligrams of MDMA (between 316 and 324 milligrams) were submitted to drug testing in the Netherlands (DIMS, 2023). However, this trend appears to be changing, as ecstasy tablets have tended to contain less MDMA since 2019.
Da
Surrey Young People’s Substance Use Service
Crystal MDMA was marketed as a purer product compared to ecstasy tablets, an assertion that was and remains largely true (see Section The trend of large tablets containing more MDMA may be reversing). One way to observe these cycles is to monitor rates of adulteration, as expressed by the percentage of tested samples buy ecstasy of seized ecstasy tablets that contain MDMA and no other scheduled substances. Together, these two data sources suggests that the large majority of MDMA users buy the drug themselves, and that a smaller proportion obtains it for free, despite marked differences among EU countries. Some substances found in these drugs can be toxic, even at low doses and even pure MDMA can be dangerous.
Drug tests aim to detect the presence of specific substances in the body. It typically appears on drug tests as MDMA or sometimes under its street names, Ecstasy or Molly. MDMA stands for 3,4-methylenedioxymethamphetamine, a synthetic drug known for its stimulant and psychedelic properties. Neurologically speaking, Ecstasy tickles all the right spots of your brain.
Harms and ris
In 2020, during the COVID-19 pandemic, almost half of the cities (24 of 49) reported a decrease in MDMA levels, with 18 reporting an increase. The data show that large quantities of MDMA are used in cities in Belgium, Czechia, the Netherlands, Spain and Portugal. The latest available data suggest an overall relatively stable level of consumption of MDMA in the European Union, although there are variations at national level. According to Dutch Police, these tablets are sold to distributors at EUR 0.59 per unit (2022 values), who in turn re-sell them at EUR 1.78 each (for quantities above 99 tablets). Profits generated by the sale of MDMA tablets buy ecstasy are expected to be significant given the volume of the trade. The effect appeared to have been short-lived, and by the end of 2020 the price returned to pre-pandemic values (NPNL, 2022
Despite their image as risk-taking hedonists, people who use drugs recreationally do seek out and share harm reduction strategies, often alongside ‘pleasure maximisation’ strategies (the latter often requiring considerable knowledge of drug research, policy and practice
Almost two thirds (503) of all new treatment entrants were reported from three countries, Germany (213); France (169) and Hungary (121). At EU and country level, people seeking drug treatment for MDMA-related problems represent a very small proportion of all clients entering drug treatment – typically less than 0.5 % of all new entrants into drug treatment in any given year. Demographic insights obtained from drug-related emergencies are in general buy ecstasy agreement with other data sources (see Section Prevalence and patterns of use).
MDMA rarely cited as a reason for entering drug treatment in Europe
By combining these data, the estimated annual value of the retail market for MDMA in Europe is at least EUR 594 million, around 90 % of which can be attributed to frequent users. The price data used was the average retail price for MDMA in
buy ecstasy the country concerned, drawn from the EUDA’s annual data collection (see Section Price and purity). For some countries (Belgium, Croatia, Denmark, France, Malta, Netherlands, Norway and Türkiye) no data were available from the EWSD. The annual amounts used, in tablets, could be estimated for each survey participant based on their responses to questions on the number of tablets used on a typical day, multiplied by the number of days they said they used the drug in a year. As such, only last year prevalence and last month prevalence data are required to distinguish these two groups.
Reporting countries
According to survey data, the two largest MDMA consumer markets per capita in the European Union are the Netherlands and Ireland, with 6 % or more people aged 15 to 34 reporting to have consumed MDMA in the last year. Some of the high-strength ecstasy tablets are scored to allow consumers to divide them into smaller portions. These identifications of high-strength ecstasy tablets prompted harm reduction organisations to issue alerts. In December 2023, beige-golden ecstasy pills with an Audi-logo containing over 300 milligrams of MDMA (between 316 and 324 milligrams) were submitted to drug testing in the Netherlands (DIMS, 2023). However, this trend appears to be changing, as ecstasy tablets have tended to contain less MDMA since 201